MARKET

SEPN

SEPN

Septerna, Inc.
NASDAQ
52.34
+1.60
+3.15%
Closed 19:34 11/10 EST
OPEN
49.35
PREV CLOSE
50.74
HIGH
52.54
LOW
46.84
VOLUME
537.69K
TURNOVER
--
52 WEEK HIGH
52.54
52 WEEK LOW
17.98
MARKET CAP
2.44B
P/E (TTM)
-40.5705
1D
5D
1M
3M
1Y
5Y
1D
Septerna: The SEP-479 Readout Could Unlock Further Upside
Seeking Alpha · 3h ago
Septerna Is Maintained at Buy by Stifel
Dow Jones · 23h ago
Septerna Price Target Raised to $60.00/Share From $49.00 by Stifel
Dow Jones · 23h ago
Stifel Maintains Buy on Septerna, Raises Price Target to $60
Benzinga · 23h ago
Cantor Fitzgerald Keeps Their Buy Rating on Septerna, Inc. (SEPN)
TipRanks · 1d ago
Wells Fargo Sticks to Its Buy Rating for Septerna, Inc. (SEPN)
TipRanks · 1d ago
Septerna, Inc. (SEPN) Receives a Buy from H.C. Wainwright
TipRanks · 1d ago
Septerna Reports Q3 Results; Advances SEP-479 And SEP-204 Toward Phase 1 Milestones In 2027
NASDAQ · 1d ago
More
About SEPN
Septerna, Inc. is a clinical-stage biotechnology company. The Company is developing G protein-coupled receptor (GPCR) oral small-molecule drug discovery powered by its proprietary Native Complex Platform. It is advancing programs in endocrinology, immunology and inflammation, metabolic diseases and additional therapeutic areas, both independently and with partners. The Company's Native Complex Platform is designed to enable it to target certain GPCRs for the first time, uncover novel binding pockets for validated receptors, and pursue a wide spectrum of pharmacologies, including agonists, antagonists, and allosteric modulators, to achieve desired therapeutic effects. It is advancing a deep portfolio of oral small molecule GPCR-targeted programs with novel mechanistic approaches to treat diseases across multiple therapeutic areas for patients with significant unmet needs. It is focused on therapeutic areas, such as neurology, women’s health, cardiovascular, and respiratory disease.

Webull offers Septerna, Inc. stock information, including NASDAQ: SEPN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SEPN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SEPN stock methods without spending real money on the virtual paper trading platform.